From: Mismatch repair and treatment resistance in ovarian cancer
 | MSI | MS markers | Histology | |||||||
---|---|---|---|---|---|---|---|---|---|---|
 |  |  | NCI-CP | total | SE | EN | CC | MU | MM | PD |
Helleman et al. | 0/75 | (0%) | 2 | 2 | 0/36 (0%) | 0/13 (0%) | 0/3 (0%) | 0/10 (0%) | 0/8 (0%) | 0/3 (0%) |
Mesquita et al.2005 | 0/34 | (0%) | 1 | 2 | 0/26 (0%) | - | 0/8 (0%) | - | - | - |
Gifford et al. 2004 | 2/138 | (1%) | 3 | 6 | Not mentioned | |||||
Catasus et al. 2004 | 5/54 | (9%) | 5 | 5 | EN, CC and MM histology | |||||
Cai et al.2004 | 6/42 | (14%) | 5 | 5 | - | - | 6/42 (14%) | - | - | - |
Liu et al.2004 | 15/74 | (20%) | 4 | 4 | - | 15/74 (20%) | - | - | - | - |
Singer et al.2004 | 6/75 | (8%) | 5 | 11 | 5/53 (9%) | 1/14 (7%) | 0/3 (0%) | 0/5 (0%) | - | - |
Geisler et al.2003 | 21/125 | (17%) | 5 | 6 | 10/69 (14%) | 6/22 (27%) | 0/4 (0%) | 2/9 (22%) | - | 1/2 (50%) |
Watanabe et al. 2001 | 2/24 | (8%) | 5 | 10 | Not mentioned | |||||
Sood et al. 2001 | 13/109 | (12%) | 5 | 14 | Not mentioned | |||||
Gras et al.2001 | 7/76 | (9%) | 5 | 10 | 0/17 (0%) | 1/48 (2%) | 1/8 (13%) | 0/2 (0%) | 0/6 (0%) | - |
Buller et al. 2001 | 22/56 | (39%) | 5 | 6 | Not mentioned | |||||
Chiaravalli et al.2001 | 3/16 | (19%) | 2 | 3 | 0/8 (0%) | 1/2 (50%) | - | 2/4 (50%) | - | 0/2 (0%) |
Ohwada et al.2000 | 15/61 | (25%) | 1 | 5 | 4/32 (13%) | - | - | 11/29 (38%) | - | - |
Allen et al.2000 | 1/25 | (4%) | 2 | 4 | 1/16 (6%) | 0/2 (0%) | 0/2 (0%) | 0/1 (0%) | - | 0/4 (0%) |
Colella et al. 1998 | 3/20 | (15%) | 0 | 3 | Not mentioned | |||||
Sood et al. 1997 | 13/78 | (17%) | 1 | 9 | Not mentioned | |||||
Sood et al. 1996 | 11/68 | (16%) | 1 | 9 | 34 serous and 34 not serous | |||||
Tangir et al.1996 | 2/31 | (6%) | 0 | 13 | 2/31 (6%) | - | - | - | - | - |
Arzimanoglou et al. 1996 | 11/90 | (12%) | 1 | 3 | Not mentioned | |||||
Fujita et al.1995 | 7/44 | (16%) | 0 | 4 | 2/22 (9%) | 5/10 (50%) | 0/4 (0%) | 0/8 (0%) | - | - |
Total | 165/1315 | (13%) | Â | Â | 24/310 (8%) | 29/185 (16%) | 7/74 (9%) | 15/68 (22%) | 0/14 (0%) | 1/11 (9%) |